Anticoagulation Therapy in Atrial Fibrillation and Congestive Heart Failure

被引：0
|
作者：
Tatarsky, B. A. [1 ]
Kazennova, N. V. [1 ]
机构：
[1] Almazov Fed North West Med Res Ctr, St Petersburg, Russia
来源：
KARDIOLOGIYA | 2016年 / 56卷 / 03期
关键词：
atrial fibrillation; heart failure; oral anticoagulant; warfarin; bleeding; VENTRICULAR SYSTOLIC DYSFUNCTION; TACHYCARDIA-INDUCED CARDIOMYOPATHY; ORAL ANTICOAGULANTS; STROKE PREVENTION; WARFARIN; EFFICACY; SAFETY; RISK; METAANALYSIS; MORTALITY;
D O I：
10.18565/cardio.2016.3.54-59
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Modern data on the need to appoint oral anticoagulants in patients with atrial fibrillation and concomitant heart failure. Based on the Phase Ill study analysis comparing the direct oral anticoagulant warfarin and meta-analysis shows that taking direct oral coagulants no less effective and safer than warfarin in patients with atrial fibrillation and heart failure, which affects significantly fewer intracranial and heavy bleeding.
引用
收藏
页码：54 / 59
页数：6
相关论文
共 50 条
  • [1] Anticoagulation in atrial fibrillation with heart failure
    Zhao, Lei
    Wang, William Y. S.
    Yang, Xinchun
    HEART FAILURE REVIEWS, 2018, 23 (04) : 563 - 571
  • [2] Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study
    Moeckel, Martin
    Pudasaini, Samipa
    Baberg, Henning Thomas
    Levenson, Benny
    Malzahn, Juergen
    Mansky, Thomas
    Michels, Guido
    Guenster, Christian
    Jeschke, Elke
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 395
  • [3] Clinical outcomes and anticoagulation therapy in elderly non-valvular atrial fibrillation and heart failure patients
    Ikeda, Shota
    Hiasa, Ken-ichi
    Inoue, Hiroshi
    Yamashita, Takeshi
    Akao, Masaharu
    Atarashi, Hirotsugu
    Koretsune, Yukihiro
    Okumura, Ken
    Shimizu, Wataru
    Suzuki, Shinya
    Ikeda, Takanori
    Toyoda, Kazunori
    Hirayama, Atsushi
    Yasaka, Masahiro
    Yamaguchi, Takenori
    Teramukai, Satoshi
    Kimura, Tetsuya
    Morishima, Yoshiyuki
    Takita, Atsushi
    Tsutsui, Hiroyuki
    ESC HEART FAILURE, 2024, 11 (02): : 902 - 913
  • [4] PROBLEMS OF ANTICOAGULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: ROLE OF RIVAROXABAN
    Kobalava, Zh. D.
    Villevalde, S. V.
    Troitskaya, E. A.
    KARDIOLOGIYA, 2018, 58 : 33 - 41
  • [5] Atrial fibrillation and congestive heart failure
    Bourke, T.
    Boyle, N. G.
    MINERVA MEDICA, 2009, 100 (02) : 137 - 143
  • [6] Anticoagulation in atrial fibrillation and chronic heart failure: the risk and drug of choice
    Boos, Christopher J.
    Brown, Louise
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (02) : 229 - 234
  • [7] Associations Between Anticoagulation Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Atrial Fibrillation
    Hernandez, Adrian F.
    Liang, Li
    Fonarow, Gregg C.
    Hammill, Bradley G.
    Hammill, Stephen C.
    Heidenreich, Paul A.
    Masoudi, Frederick A.
    Qualls, Laura G.
    Al-Khatib, Sana M.
    Piccini, Jonathan P.
    Curtis, Lesley H.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (05): : 670 - 679
  • [8] Frontiers of anticoagulation therapy for atrial fibrillation
    Yamashita, Takeshi
    JOURNAL OF CARDIOLOGY, 2011, 58 (01) : 1 - 5
  • [9] Atrial Fibrillation in Congestive Heart Failure
    Seiler, Jens
    Stevenson, William G.
    CARDIOLOGY IN REVIEW, 2010, 18 (01) : 38 - 50
  • [10] Atrial fibrillation and congestive heart failure
    Roy, Denis
    Talajic, Mario
    Dubuc, Marc
    Thibault, Bernard
    Guerra, Peter
    Macle, Laurent
    Khairy, Paul
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (01) : 29 - 34
12345